Overview - ISO 14607:2024 (Mammary implants)
ISO 14607:2024 is the fourth edition of the International Standard that sets specific requirements for mammary implants (a level‑3 standard for non‑active surgical implants). It defines safety and performance expectations covering intended performance, design attributes, materials, design evaluation, manufacturing, sterilization, packaging and the information supplied by the manufacturer. The standard replaces ISO 14607:2018 and aligns with higher‑level requirements in ISO 14630 (general requirements for non‑active surgical implants).
Key topics and technical requirements
ISO 14607:2024 organizes requirements into clearly defined clauses and normative annexes. Key technical topics include:
- Intended performance and design attributes - requirements that implants must meet to achieve their clinical purpose.
- Materials and chemical characterization - documentation, physico‑mechanical characterization, cytotoxicity, silicone gel residual oligomers and trace elements (limits and intentionally added elements).
- Design evaluation - pre‑clinical testing (mechanical, physical, chemical and biological evaluations), implantation studies and clinical evaluation plans.
- Manufacturing, sterilization and packaging - processes and controls to ensure product integrity and sterile barrier systems.
- Information supplied by the manufacturer - marking on implants, labels, instructions for use, patient information brochures and implant cards (including new surface‑category labeling).
- Post‑market surveillance - requirements for ongoing safety monitoring once devices are on the market.
- Surface and particulate contamination - expanded surface classification and new tests for surface particulate contamination.
Normative annexes cover specific test methods and reporting requirements (e.g., shell integrity, mechanical tests in implantable state, valve competence, silicone gel cohesion and penetration, surface classification, patient information templates).
Practical applications - who uses ISO 14607:2024
This standard is essential for organizations involved in the lifecycle of mammary implants, including:
- Implant manufacturers - design, testing, material selection, labeling and quality systems.
- Regulatory and compliance teams - preparing technical files, conformity assessment and responding to audits.
- Test laboratories and contract manufacturers - performing mechanical, chemical and biological testing per the annex methods.
- Clinicians and procurement specialists - understanding labeling, expected lifetime and patient information requirements.
- Post‑market surveillance and risk‑management professionals - establishing monitoring and reporting processes.
Related standards (selected)
- ISO 14630 (General requirements for non‑active surgical implants)
- ISO 10993 series (Biological evaluation of medical devices)
- ISO 14971 (Risk management for medical devices)
- ISO 11607 (Packaging for terminally sterilized medical devices)
- ISO 20417 (Information supplied by the manufacturer)
ISO 14607:2024 provides a comprehensive, up‑to‑date framework for the safe design, testing and management of mammary implants and should be used in conjunction with applicable level‑1 and level‑2 standards and local regulatory requirements.
